User:BetaCellBoyd
Editor·2,866 edits·since 2025/03
BetaCellBoyd is an editor on PeptidePedia Wiki, editing since 2025 / 3.
This editor works mainly on incretin biology and receptor pharmacology. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
2,866Total edits
36Logged here
24Articles touched
2025/03Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is incretin biology and receptor pharmacology.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Dipeptidyl peptidase-4 | 3 | 33 | 9% |
| Third-party testing | 2 | 39 | 5% |
| Glucose-dependent insulinotropic polypeptide | 2 | 33 | 6% |
| GLP-1 receptor | 2 | 37 | 5% |
| Satiety signalling | 2 | 28 | 7% |
| Gastric emptying | 1 | 26 | 4% |
| Bacteriostatic water | 1 | 33 | 3% |
| Receptor bias | 1 | 31 | 3% |
| AmbioPharm | 1 | 37 | 3% |
| Xi'an Mokemei Biotechnology | 1 | 33 | 3% |
| Proglucagon | 1 | 39 | 3% |
| Guangzhou JEEP Biotechnology | 1 | 37 | 3% |
| Insulin secretion | 1 | 31 | 3% |
| Preparative HPLC purification | 1 | 33 | 3% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.